Paper3904233
Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.
Wilson AJ and 9 others. World J Surg, 1985. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Papers, record 3904233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3904233
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Tamoxifen | Major topic |
| Adult | |
| Aged | |
| Clinical Trials as Topic | |
| Combined Modality Therapy | |
| Female | |
| Humans | |
| Mastectomy | |
| Middle Aged |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6729217 | Effect of adjuvant therapy in primary breast cancer in relation to the estrogen receptor level. | Recent Results Cancer Res | 1984 | https://conductscience.org/library/papers/6729217 | PubMed |
| 2 | 6144842 | Long-term survival of women with breast cancer. | Lancet | 1984 | https://conductscience.org/library/papers/6144842 | PubMed |
| 3 | 6341335 | Chemotherapy of breast cancer: current views and results. | Int J Radiat Oncol Biol Phys | 1983 | https://conductscience.org/library/papers/6341335 | PubMed |
| 4 | 2856949 | Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. | Lancet | 1985 | https://conductscience.org/library/papers/2856949 | PubMed |
| 5 | 6403101 | Adjuvant tamoxifen for operable carcinoma of the breast: report of clinical trial by the Christie Hospital and Holt Radium Institute. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6403101 | PubMed |
| 6 | 6696816 | Prospects for the future in the management of carcinoma of the breast: the biological fall out from clinical trials. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6696816 | PubMed |
| 7 | 6994873 | The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings. | Cancer | 1980 | https://conductscience.org/library/papers/6994873 | PubMed |
| 8 | 3883168 | Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. | N Engl J Med | 1985 | https://conductscience.org/library/papers/3883168 | PubMed |
| 9 | 7066649 | Adjuvant tamoxifen therapy for early breast cancer: an experimental study with reference to oestrogen and progesterone receptors. | Br J Surg | 1982 | https://conductscience.org/library/papers/7066649 | PubMed |
| 10 | 6150246 | Review of mortality results in randomised trials in early breast cancer. | Lancet | 1984 | https://conductscience.org/library/papers/6150246 | PubMed |
| 11 | 5965580 | Contrasting endocrine activities of cis and trans isomers in a series of substituted triphenylethylenes. | Nature | 1966 | https://conductscience.org/library/papers/5965580 | PubMed |
| 12 | 870163 | Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer. | Cancer | 1977 | https://conductscience.org/library/papers/870163 | PubMed |
| 13 | 6130291 | Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer. Interim analysis at four years by Nolvadex Adjuvant Trial Organisation. | Lancet | 1983 | https://conductscience.org/library/papers/6130291 | PubMed |
| 14 | 5115829 | A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474. | Br J Cancer | 1971 | https://conductscience.org/library/papers/5115829 | PubMed |
| 15 | 6135926 | Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer. | Lancet | 1983 | https://conductscience.org/library/papers/6135926 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 21966433 | Partial inhibition of estrogen-induced mammary carcinogenesis in rats by tamoxifen: balance between oxidant stress and estrogen responsiveness. | PLoS One | 2011 | https://conductscience.org/library/papers/21966433 | PubMed |
| 16734724 | DNA damage and altered gene expression of enzymes for metabolism and DNA repair by tamoxifen and toremifene in the female rat liver. | Cancer Sci | 2006 | https://conductscience.org/library/papers/16734724 | PubMed |
| 12841865 | The gene expression of hepatic proteins responsible for DNA repair and cell proliferation in tamoxifen-induced hepatocarcinogenesis. | Cancer Sci | 2003 | https://conductscience.org/library/papers/12841865 | PubMed |
| 10895801 | Gynecologic effects of tamoxifen: case reports and review of the literature. | Int Urogynecol J Pelvic Floor Dysfunct | 1996 | https://conductscience.org/library/papers/10895801 | PubMed |
| 3620714 | Progesterone binding cyst protein (PBCP) in primary breast cancer: a new prognostic factor? | Breast Cancer Res Treat | 1987 | https://conductscience.org/library/papers/3620714 | PubMed |
| 3543533 | The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer. | Med Oncol Tumor Pharmacother | 1986 | https://conductscience.org/library/papers/3543533 | PubMed |
| 3219274 | Prednisolone improves the response to primary endocrine treatment for advanced breast cancer. | Br J Cancer | 1988 | https://conductscience.org/library/papers/3219274 | PubMed |
| 2900646 | Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party. | Br J Cancer | 1988 | https://conductscience.org/library/papers/2900646 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3904233
GET https://conductscience.org/api/papers/v1/3904233/authors